WHO lists 9th COVID-19 vaccine for emergency use
The vaccine is produced by the Serum Institute of India, under licence from Novavax, and will now be part of the COVAX facility portfolio, boosting efforts to vaccinate more people in lower-income countries. WHO Assistant-Director General for Access to Medicines and Health Products, Dr. Mariângela Simão, said that “even with new variants emerging, vaccines remain one of the most effective tools to protect people against serious illness and death from SARS-COV-2.” She said WHO…
Read More
